Monopar Therapeutics (MNPR) › Total AssetsMonopar Therapeutics (MNPR) — Total AssetsAnnual figures by fiscal year, from SEC filings.2016: $2.90M2017: $9.93M2018: $7.32M2019: $13.35M2020: $16.87M2021: $20.52M2022: $13.23M2023: $7.35M2024: $60.29M2025: $140.72M$140.72M2016Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$140.72M+133.4%2024$60.29M+720.8%2023$7.35M-44.5%2022$13.23M-35.5%2021$20.52M+21.7%2020$16.87M+26.3%2019$13.35M+82.5%2018$7.32M-26.3%2017$9.93M+243.0%2016$2.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share